BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16810429)

  • 21. Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.
    Kohli V; Singhal A; Elliott L; Jalil S
    Transpl Int; 2012 Feb; 25(2):192-200. PubMed ID: 22151471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
    Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
    Pradat P; Tillmann HL; Sauleda S; Braconier JH; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban JI; Hadziyannis S; Rizzetto M; Thomas H; Manns MP; Trepo C;
    J Viral Hepat; 2007 Aug; 14(8):556-63. PubMed ID: 17650289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
    Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P
    J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplant for viral hepatitis and fulminant hepatic failure.
    Mukherjee S; Mahmoudi TM; Mukherjee U
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):83-100. PubMed ID: 19212311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients seeking liver transplant turn to China: outcomes of 15 Egyptian patients who went to China for a deceased-donor liver transplant.
    Abdeldayem HM; Salama I; Soliman S; Gameel K; Gabal AA; El Ella KA; Helmy A
    Exp Clin Transplant; 2008 Sep; 6(3):194-8. PubMed ID: 18954296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
    Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
    Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation at Stanford University Medical Center.
    Millan MT; Keeffe EB; Berquist WE; Castillo RO; Cox KL; Garcia G; Imperial JC; Monge H; So SK; Esquivel CO
    Clin Transpl; 1998; ():287-96. PubMed ID: 10503106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver transplantation for patients with hepatitis B/C virus cirrhosis or hepato cellular carcinoma].
    Todo S; Furukawa H; Matsushita M; Shimamura T; Jin MB; Suzuki T; Taniguchi M
    Nihon Geka Gakkai Zasshi; 2002 May; 103(5):408-13. PubMed ID: 12048876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term post-liver transplant complications of renal impairment and diabetes mellitus: data from Singapore.
    Sutedja DS; Wai CT; Teoh KF; Lee YM; Diddapur RK; Isaac J; Mak K; Da Costa M; Lee KH; Prabhakaran K; Tan KC; Lim SG
    Singapore Med J; 2006 Jul; 47(7):604-8. PubMed ID: 16810433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C in children: a quaternary referral center perspective.
    Rumbo C; Fawaz RL; Emre SH; Suchy FJ; Kerkar N; Morotti RA; Shneider BL
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):209-16. PubMed ID: 16877987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
    Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.